TRDA- Entrada Therapeutics, Inc.

Name: Entrada Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Entrada Therapeutics, Inc. (TRDA) has 12 insiders with recent SEC Form 4 filings, including 16 buys and 11 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	5am Ventures V, L.P.	2.96M	$19.73M	-
10%	Parmar Kush	2.96M	$19.73M	-
CEO	Doshi Dipal	526.0K	$3.50M	-
10%	Baker Bros. Advisors LP	381.3K	$2.54M	-
Pres	Sethuraman Natarajan	216.3K	$1.44M	-25,907

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 4, 2026	Sethuraman Natarajan83	President, Research &Develop.	Sell	25,907	$15.39	$398,809.77	-10.7%	-	-
May 4, 2026	Dowden Nathan J70	President &COO	Sale+OE	15,000	$15.33	$229,953.00	-7.0%	-	-
Mar 10, 2026	Wentworth Kory James61	Chief Financial Officer	Sell	16,477	$13.01	$214,378.56	-6.1%	-	-
Mar 10, 2026	Dowden Nathan J70	President &COO	Sell	15,010	$13.04	$195,770.94	-3.5%	-	-
Nov 21, 2025	Wentworth Kory James61	Chief Financial Officer	Sell	8,910	$9.98	$88,931.60	-7.5%	+12.9%	-
Nov 20, 2025	Baker Bros. Advisors LP59	10% Owner	Buy	28,867	$9.07	$261,846.12	+0.3%	+20.4%	-
Nov 14, 2025	5am Ventures V, L.P.72	10% Owner	Sell	200,000	$8.80	$1,760,000.00	-6.3%	+23.4%	-
Nov 14, 2025	Parmar Kush67	Director, 10% Owner	Sell	200,000	$8.80	$1,760,000.00	-6.3%	+23.4%	-
Nov 12, 2025	Baker Bros. Advisors LP59	10% Owner	Buy	178,044	$7.60	$1,352,586.68	+0.6%	+35.1%	-
Jul 9, 2025	5am Ventures V, L.P.72	10% Owner	Sell	27,000	$7.50	$202,554.00	-0.6%	-22.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC